(BRK-B) Berkshire Hathaway - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0846707026
Stock: Insurance, Railroads, Energy, Manufacturing, Retail
Total Rating 32
Risk 71
Buy Signal -0.84
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 15.3% |
| Relative Tail Risk | -0.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.04 |
| Alpha | -8.42 |
| Character TTM | |
|---|---|
| Beta | 0.479 |
| Beta Downside | 0.477 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.95% |
| CAGR/Max DD | 1.03 |
Description: BRK-B Berkshire Hathaway January 26, 2026
Berkshire Hathaway Inc. (BRK-B) is a conglomerate that operates across four core pillars: insurance and reinsurance, freight rail (BNSF Railway), regulated utilities & energy infrastructure, and a diversified manufacturing & consumer-products portfolio that includes everything from confectionery to aerospace components.
Recent performance highlights underscore the weight of each pillar: the insurance segment posted a $5.7 billion underwriting profit in FY 2023, while BNSF Railway delivered a record $7.1 billion in net earnings on an 81.5 % operating ratio, reflecting strong freight demand despite a modest slowdown in rail volumes (down 1.2 % YoY). The utility segment generated $5.1 billion of operating earnings, benefitting from higher electricity rates and continued investment in renewable generation, which now accounts for roughly 27 % of the segment’s capacity mix. Key macro drivers include a low-interest-rate environment that supports insurance float, robust U.S. freight demand tied to e-commerce growth, and the energy transition pushing utilities toward cleaner generation sources.
For a deeper dive into the valuation nuances, consider checking ValueRay’s latest analyst notes.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 67.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.26 > 1.0 |
| NWC/Revenue: 126.7% < 20% (prev 82.06%; Δ 44.65% < -1%) |
| CFO/TA 0.03 > 3% & CFO 39.40b > Net Income 67.46b |
| Net Debt (74.18b) to EBITDA (98.86b): 0.75 < 3 |
| Current Ratio: 48.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.16b) vs 12m ago 0.17% < -2% |
| Gross Margin: 28.69% > 18% (prev 0.56%; Δ 2813 % > 0.5%) |
| Asset Turnover: 31.91% > 50% (prev 37.69%; Δ -5.79% > 0%) |
| Interest Coverage Ratio: 20.03 > 6 (EBITDA TTM 98.86b / Interest Expense TTM 4.28b) |
Altman Z'' 6.51
| A: 0.39 (Total Current Assets 489.78b - Total Current Liabilities 10.05b) / Total Assets 1225.96b |
| B: 0.61 (Retained Earnings 743.99b / Total Assets 1225.96b) |
| C: 0.07 (EBIT TTM 85.65b / Avg Total Assets 1186.61b) |
| D: 1.41 (Book Value of Equity 741.47b / Total Liabilities 525.52b) |
| Altman-Z'' Score: 6.51 = AAA |
Beneish M -2.09
| DSRI: 1.19 (Receivables 82.79b/79.15b, Revenue 378.61b/432.44b) |
| GMI: 1.96 (GM 28.69% / 56.21%) |
| AQI: 0.96 (AQ_t 0.41 / AQ_t-1 0.43) |
| SGI: 0.88 (Revenue 378.61b / 432.44b) |
| TATA: 0.02 (NI 67.46b - CFO 39.40b) / TA 1225.96b) |
| Beneish M-Score: -2.09 (Cap -4..+1) = BB |
What is the price of BRK-B shares?
As of January 30, 2026, the stock is trading at USD 476.79 with a total of 5,301,105 shares traded.
Over the past week, the price has changed by -1.59%, over one month by -4.84%, over three months by +0.22% and over the past year by +1.60%.
Over the past week, the price has changed by -1.59%, over one month by -4.84%, over three months by +0.22% and over the past year by +1.60%.
Is BRK-B a buy, sell or hold?
Berkshire Hathaway has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy BRK-B.
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BRK-B price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 528.7 | 10.9% |
| Analysts Target Price | 528.7 | 10.9% |
| ValueRay Target Price | 531.7 | 11.5% |
BRK-B Fundamental Data Overview January 29, 2026
P/E Trailing = 15.1749
P/E Forward = 21.5517
P/S = 2.7518
P/B = 1.4668
P/EG = 10.0559
Revenue TTM = 378.61b USD
EBIT TTM = 85.65b USD
EBITDA TTM = 98.86b USD
Long Term Debt = 124.20b USD (from longTermDebt, last quarter)
Short Term Debt = 26.28b USD (from shortTermDebt, last quarter)
Debt = 150.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 74.18b USD (from netDebt column, last quarter)
Enterprise Value = 1098.20b USD (1024.02b + Debt 150.48b - CCE 76.31b)
Interest Coverage Ratio = 20.03 (Ebit TTM 85.65b / Interest Expense TTM 4.28b)
EV/FCF = 56.83x (Enterprise Value 1098.20b / FCF TTM 19.33b)
FCF Yield = 1.76% (FCF TTM 19.33b / Enterprise Value 1098.20b)
FCF Margin = 5.10% (FCF TTM 19.33b / Revenue TTM 378.61b)
Net Margin = 17.82% (Net Income TTM 67.46b / Revenue TTM 378.61b)
Gross Margin = 28.69% ((Revenue TTM 378.61b - Cost of Revenue TTM 269.97b) / Revenue TTM)
Gross Margin QoQ = 23.29% (prev 44.56%)
Tobins Q-Ratio = 0.90 (Enterprise Value 1098.20b / Total Assets 1225.96b)
Interest Expense / Debt = 0.22% (Interest Expense 325.0m / Debt 150.48b)
Taxrate = 19.00% (7.24b / 38.10b)
NOPAT = 69.37b (EBIT 85.65b * (1 - 19.00%))
Current Ratio = 48.72 (Total Current Assets 489.78b / Total Current Liabilities 10.05b)
Debt / Equity = 0.21 (Debt 150.48b / totalStockholderEquity, last quarter 700.44b)
Debt / EBITDA = 0.75 (Net Debt 74.18b / EBITDA 98.86b)
Debt / FCF = 3.84 (Net Debt 74.18b / FCF TTM 19.33b)
Total Stockholder Equity = 668.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.69% (Net Income 67.46b / Total Assets 1225.96b)
RoE = 10.10% (Net Income TTM 67.46b / Total Stockholder Equity 668.07b)
RoCE = 10.81% (EBIT 85.65b / Capital Employed (Equity 668.07b + L.T.Debt 124.20b))
RoIC = 8.86% (NOPAT 69.37b / Invested Capital 783.18b)
WACC = 6.72% (E(1024.02b)/V(1174.51b) * Re(7.68%) + D(150.48b)/V(1174.51b) * Rd(0.22%) * (1-Tc(0.19)))
Discount Rate = 7.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.34%
[DCF Debug] Terminal Value 82.62% ; FCFF base≈20.01b ; Y1≈19.39b ; Y5≈19.27b
Fair Price DCF = 276.8 (EV 454.11b - Net Debt 74.18b = Equity 379.93b / Shares 1.37b; r=6.72% [WACC]; 5y FCF grow -4.27% → 2.90% )
EPS Correlation: 83.81 | EPS CAGR: 18.91% | SUE: 0.39 | # QB: 0
Revenue Correlation: 38.05 | Revenue CAGR: 31.74% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=5.23 | Chg30d=-0.275 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=24.19 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+13.6% | Growth Revenue=+3.5%
P/E Forward = 21.5517
P/S = 2.7518
P/B = 1.4668
P/EG = 10.0559
Revenue TTM = 378.61b USD
EBIT TTM = 85.65b USD
EBITDA TTM = 98.86b USD
Long Term Debt = 124.20b USD (from longTermDebt, last quarter)
Short Term Debt = 26.28b USD (from shortTermDebt, last quarter)
Debt = 150.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 74.18b USD (from netDebt column, last quarter)
Enterprise Value = 1098.20b USD (1024.02b + Debt 150.48b - CCE 76.31b)
Interest Coverage Ratio = 20.03 (Ebit TTM 85.65b / Interest Expense TTM 4.28b)
EV/FCF = 56.83x (Enterprise Value 1098.20b / FCF TTM 19.33b)
FCF Yield = 1.76% (FCF TTM 19.33b / Enterprise Value 1098.20b)
FCF Margin = 5.10% (FCF TTM 19.33b / Revenue TTM 378.61b)
Net Margin = 17.82% (Net Income TTM 67.46b / Revenue TTM 378.61b)
Gross Margin = 28.69% ((Revenue TTM 378.61b - Cost of Revenue TTM 269.97b) / Revenue TTM)
Gross Margin QoQ = 23.29% (prev 44.56%)
Tobins Q-Ratio = 0.90 (Enterprise Value 1098.20b / Total Assets 1225.96b)
Interest Expense / Debt = 0.22% (Interest Expense 325.0m / Debt 150.48b)
Taxrate = 19.00% (7.24b / 38.10b)
NOPAT = 69.37b (EBIT 85.65b * (1 - 19.00%))
Current Ratio = 48.72 (Total Current Assets 489.78b / Total Current Liabilities 10.05b)
Debt / Equity = 0.21 (Debt 150.48b / totalStockholderEquity, last quarter 700.44b)
Debt / EBITDA = 0.75 (Net Debt 74.18b / EBITDA 98.86b)
Debt / FCF = 3.84 (Net Debt 74.18b / FCF TTM 19.33b)
Total Stockholder Equity = 668.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.69% (Net Income 67.46b / Total Assets 1225.96b)
RoE = 10.10% (Net Income TTM 67.46b / Total Stockholder Equity 668.07b)
RoCE = 10.81% (EBIT 85.65b / Capital Employed (Equity 668.07b + L.T.Debt 124.20b))
RoIC = 8.86% (NOPAT 69.37b / Invested Capital 783.18b)
WACC = 6.72% (E(1024.02b)/V(1174.51b) * Re(7.68%) + D(150.48b)/V(1174.51b) * Rd(0.22%) * (1-Tc(0.19)))
Discount Rate = 7.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.34%
[DCF Debug] Terminal Value 82.62% ; FCFF base≈20.01b ; Y1≈19.39b ; Y5≈19.27b
Fair Price DCF = 276.8 (EV 454.11b - Net Debt 74.18b = Equity 379.93b / Shares 1.37b; r=6.72% [WACC]; 5y FCF grow -4.27% → 2.90% )
EPS Correlation: 83.81 | EPS CAGR: 18.91% | SUE: 0.39 | # QB: 0
Revenue Correlation: 38.05 | Revenue CAGR: 31.74% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=5.23 | Chg30d=-0.275 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=24.19 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+13.6% | Growth Revenue=+3.5%